Blueprint Medicines Corporation

Blueprint Medicines Corporation

World Rank (Jan-05-2024)
2,761
Market Cap (Jan-05-2024)
5.394 Billion USD
World Rank (Jul-30-2023)
3,655
Market Cap (Jul-30-2023)
3.817 Billion USD
World Rank (Jan-07-2022)
3,090
Market Cap (Jan-07-2022)
5.381 Billion USD
World Rank (Jan-01-2021)
2,473
Market Cap (Jan-01-2021)
6.250 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
BPMC
Employee Count
383
Employee Count as of Date
As on 2020
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
204 Million USD
Annual Operating Income in USD
-537 Million USD
Annual Net Income in USD
-557 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
1,349 Million USD
Total Liabilities in USD
835 Million USD
Total Equity in USD
514 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Pharmaceutical
Biotechnology
Technology
HealthCare Products
Company Website
BLUEPRINT MEDICINES CORPORATION
Yahoo
Yahoo @ Nasdaq
Company Profile

Bio-pharmaceutical company with headquarters is in Massachusetts, USA.

Annual Results Summary

BLUEPRINT MEDICINES CORPORATION - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022204-537-557
Dec-2021180-64-644
Dec-2020793 308 313
Dec-201966-361-347
Dec-201844-247-236
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,349 Million USD.

Total Liabilities as on Dec-2022 was 835 Million USD.

Total Equity as on Dec-2022 was 514 Million USD.

Founded Year
2008
IPO Year
2015
Stock Exchange
Nasdaq
Company SubCategory
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Pharmaceutical Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share